Stille

Stille EPS Growth

The EPS Growth of Stille (STIL.ST) as of Oct 24, 2026 is -3.96 %. In the previous year, EPS Growth was 22.02 % — a change of -118.00% (lower).

EPS Growth

-3.96 %

YoY

-118.00%

Last updated:

EPS Growth of Stille is 2025 -3.96 % . EPS Growth of Stille was 2024 22.02 % . It decreases by -118.00% lower compared to the previous year.

The Stille EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
43.95 SEK
Jan 1, 2019
13.63 SEK
Jan 1, 2020
-63.62 SEK
Jan 1, 2021
86.00 SEK
Jan 1, 2022
69.58 SEK
Jan 1, 2023
-2.66 SEK
Jan 1, 2024
22.02 SEK
Jan 1, 2025
-3.96 SEK
The Stille EPS Growth history
YEAREPS GrowthYoY
-3.96 %-118.00%
22.02 %-929.03%
-2.66 %-103.82%
69.58 %-19.08%
86.00 %-235.16%
-63.62 %-566.90%
13.63 %-68.99%
43.95 %-358.56%
-17.00 %-127.19%
62.51 %-86.07%
448.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

EPS Growth of Stille is -3.96 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Stille since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Stille historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Stille

All Key Metrics — Stille